Saturday 31 May, 2025 03:22 AM
Site map | Locate Us | Login
   SML Isuzu gains after Q4 PAT rises 1% YoY to Rs 53 cr    Alembic Pharma receives USFDA final approval for Bosutinib tablets    Dynamic Cables gains after board declares 1:1 bonus issue    Samhi Hotels Q4 PAT jumps 306% YoY to Rs 46 cr    Welspun Living Ltd leads losers in 'A' group    Sobha gains after Q4 PAT soars 481% YoY to Rs 41 cr    Kiri Industries Ltd leads losers in 'B' group    SJVN slumps on reporting dismal Q4 PAT    Crisil Ratings assigns 'A1+' rating to commercial paper of Muthoot Microfin    Volumes soar at Gujarat Pipavav Port Ltd counter    ICRA reaffirms ratings of Ethos at 'A+' with 'stable' outlook    EFC (I) surges after PAT rises over 71% YoY in Q4; EBITDA margin at 51.8%    Metal shares fall    United Spirits Ltd down for fifth straight session    KNR Constructions slides as Q4 PAT slumps 61% YoY to Rs 248 cr 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Deepak Nitrite rallies after Q4 PAT soars 106% QoQ to Rs 202 cr
29-May-25   11:26 Hrs IST

On year on year (YoY) basis, the company's consolidated revenue jumped 2.5%, while net profit declined 20.3% in Q4 FY25.

Profit before tax (PBT) declined 20.2% YoY but increased 106% QoQ to Rs 278.71 crore in Q4 FY25.

EBITDA stood at Rs 339 crore, up 6% YoY compared with Rs 320 crore posted in corresponding quarter last year. The EBITDA margin remained steady at 15% in Q4 FY25 compared to Q4 FY24.

On segmental front, the revenue from advanced intermediates was at Rs 654 crore (down 3% YoY) while revenue from phenolics stood at Rs 1,532 crore, (up 5%) during the period under review.

On full year basis, the company's consolidated net profit declined 14% to Rs 697.24 crore on 7.8% increase in revenue from operations to Rs 8,281.93 crore in FY25 over FY24.

Deepak C. Mehta, chairman & managing director said: 'With all projects coming in with entire backward and forward integration we would be poised for much more resilient operations with an improved bottom line performance. In these turbulent times backward and forward integration go a longway in ensuring that ultimate consumers are taken care of and both the commodity and specialty businesses support each other.

Our growth plan envisages development of further upstream products like Nitric Acid and downstream products such as MIBK, MIBC, for which capacities are set to be operationalized in the upcoming quarters. These will deepen the degree of integration across our business and strengthen our competitive position. The plan to manufacture polycarbonate resins is also taking more concrete shape and the Board of DCTL has recently approved investments for manufacturing 300 KTA of Phenol, 185 KTA of Acetone and 100 KTA of lsopropyl Alcohol (lPA) including greenfield infrastructure capex for an aggregate investment of about Rs 3,500 crore. This is over and above the present manufacturing capacity of these products and the new capacity of Phenol and Acetone will be ultimately integrated to produce Polycarbonate Resins. This approval along with the previous approval of Rs 5,000 crore of PC resins brings the aggregate investment pipeline for the PC Resin project to around Rs 8,500 crore.

As already mentioned, Deepak will be one of the largest single location producers of Phenol and Acetone in the entire world with more than half of the capacity converted into downstream derivatives such as Bisphenol A and PC Resins, etc. With the commitment to increased Research and Development Activity the new R&D Centre is scheduled to be operative during the year. We are already bringing forward new projects that would enhance our position in life sciences business as well as specialty solvents. New Products in the area of Material Sciences are also being considered based on core competencies of Deepak.'

Meanwhile, the company's board recommended a dividend of Rs 7.50 per share with a face value of Rs 2 per share for FY25, subject to approval of shareholders at ensuing annual general meeting (AGM. The dividend, if approved by shareholders at the ensuing 54th AGM of the company will be paid within 30 days from the date of AGM.

Deepak Nitrite is a leading chemical intermediates producer with a diversified portfolio that caters to the dyes and pigments, agrochemical, pharmaceutical, plastics, textiles, paper and home and personal care segments. It also manufactures petrochemical-derived intermediates such as phenolics, acetone, and isopropyl alcohol (IPA) for both domestic and international markets.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41221622
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited